COVID impact on MedTech priorities
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business. Survey respondents work in leadership...
CRA’s Life Sciences consultants have authored a variety of articles on the effects of the Covid-19 pandemic on life sciences companies, covering issues including the impact on clinical research, physician practices, and vaccine pricing, procurement, and supply. You can read a selection of our thinking below.